
Dravet Syndrome in 2024
Learning Objectives:
- Describe non-seizure related symptoms of Dravet Syndrome.
- Review treatment options available to treat Dravet Syndrome now and in the future.
- Review challenges of transition into an adult model of care for patients and families living with Dravet syndrome.

About this presenter:
Kelly G. Knupp, MD, MSCS, FAES
Professor of Pediatrics and Neurology
University of Colorado, Anschutz Medical Campus
Kelly Knupp is a Professor of Pediatrics and Neurology at the University of Colorado. She received her medical degree from the University of New Mexico - School of Medicine, completed her residency in Pediatrics at Children’s Hospital of New York followed by Pediatric Neurology Residency at Columbia University at Children’s Hospital of New York. After her residency, she trained as a Clinical Fellow in Pediatric Epilepsy at the Columbia Comprehensive Epilepsy Center at New York Presbyterian Hospital.
Dr. Knupp practices at Children’s Hospital Colorado in Aurora, CO and is the Director of the Dravet Program. Her research interests are epileptic encephalopathies including Dravet Syndrome and infantile spasms. She was a founding member of the Pediatric Epilepsy Research Consortium and continues on the board. This group focuses on developing collaborative research across the country for children with epileptic encephalopathies. She also serves on Board of the American Epilepsy Society and the medical advisory boards of the Dravet Syndrome Foundation, Coalition to Cure CHD2 and KCNQ2 Cure.